Jan Kunde
Overview
Explore the profile of Jan Kunde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piccin A, Murphy C, Eakins E, Kunde J, Corvetta D, Di Pierro A, et al.
J Extracell Vesicles
. 2015 Nov;
4:28414.
PMID: 26609806
Introduction: Circulating microparticles (MP) have been described in sickle cell anaemia (SCA); however, their interaction with endothelial markers remains unclear. We investigated the relationship between MP, protein C (PC), free...
2.
Schnabel R, Wild P, Wilde S, Ojeda F, Schulz A, Zeller T, et al.
PLoS One
. 2014 Nov;
9(11):e112486.
PMID: 25401728
Background: Different biological pathways have been related to atrial fibrillation (AF). Novel biomarkers capturing inflammation, oxidative stress, and neurohumoral activation have not been investigated comprehensively in AF. Methods And Results:...
3.
Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Doner U, Dungen H, et al.
J Card Fail
. 2014 Sep;
20(12):923-30.
PMID: 25230239
Background: Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and homoarginine are considered to modulate nitric oxide synthesis. We evaluated whether ADMA, SDMA, and homoarginine are associated with diastolic dysfunction. Methods And...
4.
Tzikas S, Keller T, Ojeda F, Zeller T, Wild P, Lubos E, et al.
Heart
. 2012 Dec;
99(6):388-95.
PMID: 23213173
Objective: To evaluate mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) as prognostic biomarkers in a representative 'real world' cohort of patients with suspected acute coronary syndrome (ACS). Design:...
5.
Tzikas S, Keller T, Wild P, Schulz A, Zwiener I, Zeller T, et al.
Clin Chem Lab Med
. 2012 Nov;
51(5):1125-33.
PMID: 23183754
Background: The use of biomarkers is firmly established for the assessment of cardiovascular disease. Emerging biomarkers such as midregional pro-atrial natriuretic peptide (MR-proANP) challenge established markers regarding risk prediction and...
6.
Schnabel R, Wild P, Schulz A, Zeller T, Sinning C, Wilde S, et al.
Hypertension
. 2012 Jun;
60(2):288-95.
PMID: 22689741
Vascular reactivity is reflected by blood biomarkers and noninvasive vascular function measurement. The relation of biomarkers to flow-mediated dilation and peripheral arterial tonometry in the general population is little understood....
7.
Gombos T, Forhecz Z, Pozsonyi Z, Szeplaki G, Kunde J, Fust G, et al.
Clin Res Cardiol
. 2012 Mar;
101(8):607-15.
PMID: 22373875
Objectives: The purpose of this study was to evaluate complement activation in a heart failure cohort. Based on their powerful biological activity, we hypothesized that the levels of anaphylatoxin C3a...
8.
Czucz J, Schaffer G, Csuka D, Walentin S, Kunde J, Prohaszka Z, et al.
J Clin Immunol
. 2011 Oct;
32(1):61-9.
PMID: 22009003
Background: The bradykinin pathway in the pathomechanism of hereditary angioedema due to C1-inhibitor deficiency (henceforward "hereditary angioedema") has been thoroughly studied; however, much less is known about endothelial cell function....
9.
Edelmann F, Stahrenberg R, Polzin F, Kockskamper A, Dungen H, Duvinage A, et al.
Am Heart J
. 2011 Apr;
161(4):797-804.
PMID: 21473981
Background: Quality of life (QoL) is impaired in diastolic heart failure. Little is known about QoL in diastolic dysfunction (DD) without heart failure. Methods: In the DIAST-CHF observational study, outpatients...
10.
Czucz J, Cervenak L, Forhecz Z, Gombos T, Pozsonyi Z, Kunde J, et al.
Clin Res Cardiol
. 2011 Feb;
100(7):587-94.
PMID: 21311898
Background: Neuroendocrine activation with endothelial dysfunction is a key pathophysiological process in chronic heart failure (CHF). Although increased soluble E-selectin (sE-selectin) levels predict adverse events in several forms of cardiovascular...